Kobo Biotech Ltd vs Sai Parenterals Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 05, 2026

Key Highlights

The Latest Trading Price of Kobo Biotech Ltd is ₹ 2.71 as of 04 May 15:30 . The P/E Ratio of Kobo Biotech Ltd is 0 as of March 2023 .The P/E Ratio of Sai Parenterals Ltd is 0 as of March 2023 . The Market Cap of Kobo Biotech Ltd is ₹ 0 crore as of March 2023 .The Market Cap of Sai Parenterals Ltd is ₹ 0 crore as of March 2023 . The Revenue of Kobo Biotech Ltd is ₹ 0.02 crore as of Jun '24 .The Revenue of Sai Parenterals Ltd is ₹ 0 crore as of Jun '24 . The EBITDA of Kobo Biotech Ltd is ₹ -0.32 crore as of Jun '24 .The EBITDA of Sai Parenterals Ltd is ₹ 0 crore as of Jun '24 . The Net Profit of Kobo Biotech Ltd is ₹ -1.33 crore as of Jun '24 .The Net Profit of Sai Parenterals Ltd is ₹ 0 crore as of Jun '24 . The Dividend Payout of Kobo Biotech Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Sai Parenterals Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Kobo Biotech Ltd

Kobo Biotech Ltd.(Formerly known Avon Lifesciences Ltd) was established as a Public Limited Company on August 3, 1992.
Effective 19th October, 2020, the Company's name was changed to Kobo Biotech Limited from erstwhile Avon Lifesciences Limited.
The Company is a customer-centric manufacturer of active pharmaceutical ingredients (API).Promoted by P R Agarwal, Rajesh Agarwal and G S Sidhu, the Company manufacture diketene and its derivatives Monomethyl Acetoncetamide(MMA) and Methyl Acetoacetate(MAA). The company's 1200 tpa Diketene manufacturing faciltiy located at Sadashivpet in Andhrapradesh and the products of it were used in pigments, pharmaceuticals and pesticides. The company has a tripartite technical knowhow agreement with Shanghai Machinery & Equipment Import and Export Corporation (SMEC), representative of Shanghai Peng Pu Chemical Works (SPCW) and Xytel Technologies Partnership (XTP), US.

About Sai Parenterals Ltd

Sai Parenteral's Limited was originally incorporated as Sai Parenteral's Private Limited', a Private Limited Company on January 12, 2001, with the Registrar of Companies, at Hyderabad.
Thereafter, Company was converted into a Public Limited Company and the name of Company was changed to Sai Parenteral's Limited' w.e.f January 17, 2022. Sai Parenteral's is a diversified pharmaceutical formulations company engaged in the business of Branded Generic Formulations and Contract Development and Manufacturing Organization (CDMO) products and services for the domestic and international markets.
Company has developed a comprehensive and diversified portfolio of complex pharmaceutical products, covering both high-value and high-volume categories addressing critical therapeutic needs across the multiple disease areas.

FAQs for the comparison of Kobo Biotech Ltd and Sai Parenterals Ltd

Which company has a larger market capitalization, Kobo Biotech Ltd or Sai Parenterals Ltd?

Market cap of Kobo Biotech Ltd is 6 Cr while Market cap of Sai Parenterals Ltd is 2,161 Cr

What are the key factors driving the stock performance of Kobo Biotech Ltd and Sai Parenterals Ltd?

The stock performance of Kobo Biotech Ltd and Sai Parenterals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Kobo Biotech Ltd and Sai Parenterals Ltd?

As of May 5, 2026, the Kobo Biotech Ltd stock price is INR ₹2.71. On the other hand, Sai Parenterals Ltd stock price is INR ₹489.35.

How do dividend payouts of Kobo Biotech Ltd and Sai Parenterals Ltd compare?

To compare the dividend payouts of Kobo Biotech Ltd and Sai Parenterals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.